New Perspectives of Interferon-alpha2 and Inflammation in Treating Philadelphia-negative Chronic Myeloproliferative Neoplasms

QR Code

New Perspectives of Interferon-alpha2 and Inflammation in Treating Philadelphia-negative Chronic Myeloproliferative Neoplasms

Enregistré dans:

Détails bibliographiques
Auteurs principaux:	Hans C. Hasselbalch, Richard T. Silver
Format:	article
Langue:	EN
Publié:	Wolters Kluwer 2021
Sujets:	Diseases of the blood and blood-forming organs RC633-647.5
Accès en ligne:	https://doaj.org/article/161b2c12c78d406dba9f9777c72a3bf4
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires

THE OUTCOME OF FATHERHOOD IN PATIENTS WITH PHILADELPHIA NEGATIVE MYELOPROLIFERATIVE NEOPLASMS, A SINGLE INSTITUTION EXPERIENCE
par: Elrazi Ali, et autres
Publié: (2021)

Spotlight on ponatinib in the treatment of chronic myeloid leukemia and Philadelphia chromosome-positive acute lymphoblastic leukemia: patient selection and perspectives [Erratum]
par: Anagnostou T, et autres
Publié: (2018)

INFLAMMATION AND CANCER
par: Jean-François Rossi
Publié: (2021)

Cytogenetic studies for cMYC, BCL2 and BCL6 genes in neoplasm: comparison of karyotype, FISH in paraffin-embedded tissue and FISH in methanol-acetic acid-fixed cells suspensions
par: Caroline Henriques Garcia, et autres
Publié: (2021)

THE APPROACH AND DIAGNOSIS OF COOMBS NEGATIVE HEMOLYTIC ANEMIAS
par: Achille Iolascon
Publié: (2021)

HOW I TREAT NEWLY DIAGNOSED MULTIPLE MYELOMA PATIENTS?
par: María-Victoria Mateos
Publié: (2021)

Treating the elderly patient with chronic lymphocytic leukemia: current and emerging options
par: Mozaheb Z
Publié: (2014)

Leptomeningeal myelomatosis in previously treated high-risk kappa light chain multiple myeloma: case report and literature review
par: Ohanian M, et autres
Publié: (2011)

ACQUIRED FACTOR XIII DEFICIENCY WITH RUNX1 MUTATION, A REPORT OF TWO CASES TREATED WITH FACTOR XIII CONCENTRATE
par: Alfadil Haroon, et autres
Publié: (2021)

REVIEW OF NEW INDICATIONS – JOURNAL OF CLINICAL APHERESIS PERSPECTIVE
par: Huy Pham
Publié: (2021)

Imatinib in the treatment of chronic myeloid leukemia: current perspectives on optimal dose
par: Waclaw J, et autres
Publié: (2015)

Trends in the treatment of cutaneous T-cell lymphoma &ndash; critical evaluation and perspectives on vorinostat
par: Zhang CL, et autres
Publié: (2012)

MicroRNA dysregulation in B-cell non-Hodgkin lymphoma
par: Lim EL, et autres
Publié: (2013)

Critical appraisal of belinostat in the management of T-cell lymphoma – patient considerations
par: Bodiford A, et autres
Publié: (2015)

The expanding role of bendamustine in chronic lymphocytic leukemia
par: Nair KS, et autres
Publié: (2015)

Bortezomib in autoimmune hemolytic anemia and beyond
par: Raffaella Pasquale, et autres
Publié: (2021)

Life-Threatening Retroperitoneal Hematoma in a Patient with COVID-19
par: Monarch Shah, et autres
Publié: (2021)

A method to determine if more than surrogate outcomes were improved: The EMR glitch experiment
par: Jennifer Gill, et autres
Publié: (2020)

All bleeding matters … but the details may not
par: Sarah H. O’Brien
Publié: (2020)

The Use of Etoposide, Ara-Cytarabine, and Melphalan (EAM) Conditioning Chemotherapy in Autologous Stem Cell Transplantation (ASCT) for a Patient with Relapsed Hodgkin’s Lymphoma
par: Eko A. Pangarsa, et autres
Publié: (2021)

PP Transcon 2020 Abstracts Compilation
Publié: (2021)

Positive/external control of rapid diagnostic tests: A step forward in malaria screening
par: Rasika D Setia, et autres
Publié: (2021)

A rare case of mistaken identity - Historical blood group saved the situation
par: Anand Deshpande, et autres
Publié: (2021)

Oration - Dr Sanmukh Joshi
Publié: (2021)

OP Transcon 2020 Abstracts Compilation
Publié: (2021)

TRANSCON 2020 45th Annual Conference ISBTI 27th & 28th Feb 2021
Publié: (2021)

Clinical relevance of hepatitis B core total antibody in the detection of occult hepatitis B infection in patients with liver disease and blood donors
par: Vijeta Bajpai, et autres
Publié: (2021)

Long-term safety and efficacy of dasatinib in the treatment of chronic-phase chronic myeloid leukemia patients resistant or intolerant to imatinib
par: Shoumariyeh K, et autres
Publié: (2014)

MYC as therapeutic target in leukemia and lymphoma
par: Cortiguera MG, et autres
Publié: (2015)

Clinical potential of carfilzomib in the treatment of relapsed and refractory multiple myeloma
par: Gupta VA, et autres
Publié: (2013)

Optimal management of endemic Burkitt lymphoma: a holistic approach mindful of limited resources
par: Moormann AM, et autres
Publié: (2014)

Peripheral T cell lymphoma: clinical utility of romidepsin
par: Sawey K, et autres
Publié: (2012)

The evaluation and optimal use of rituximab in lymphoid malignancies
par: Smolewski P, et autres
Publié: (2012)

Impact of pharmacokinetics to reduce bleeding in a cohort of patients with severe hemophilia A in a personalized comprehensive management program
par: Samuel sarmiento Doncel, et autres
Publié: (2021)

Ultrastructural alterations of megakaryocytes in thrombocytopenia: A review of 43 cases
par: Brian Eyden, et autres
Publié: (2021)

Regulation of megakaryopoiesis by bone marrow macrophage polarization
par: Ming Hou
Publié: (2021)

The correlation between Flt3-ITD mutation in dendritic cells with TIM-3 expression in acute myeloid leukemia
par: Hooriyeh Shapoorian, et autres
Publié: (2021)

Immune targeted therapy for diffuse large B cell lymphoma
par: Yaxin Zheng, et autres
Publié: (2021)

Lymphoid-biased hematopoietic stem cells and myeloid-biased hematopoietic progenitor cells have radioprotection activity
par: Shanshan Zhang, et autres
Publié: (2021)

Multiple Myeloma: EHA-ESMO Clinical Practice Guidelines for Diagnosis, Treatment and Follow-up
par: Meletios A. Dimopoulos, et autres
Publié: (2021)